Jmolner Is An Estonian Pharmaceutical Company Founded In 2015Specializing In Generic Drug Development And Analytical Chemistry Servicesheadquartered In Tallinnestoniathe Company Opened Its First U Soffice In Jersey Citynew Jerseyin 2022Jmolner Holds Licenses To Sell Drugs In Both The U Sand Canadafocusing On Sterile Injectables And Dermatology Products The Company Offers A Range Of Servicesincluding Generic Drug Developmentanalytical Chemistry Testingin Vitro Release Testingand Commercial Stability Solutionsjmolner Assists Clients With Regulatory Compliance And Market Entry In Europesupporting Both North American And European Pharmaceutical Clientsthe Company Is Led By Jason Michael Atticus Grenfell Gardnerwho Serves As Chairman Of The Management Board And Ceojmolner Is Traded On Nasdaq Tallinn Under The Ticker Molnr
